Webinar to address innovative outsourcing approaches to drug development
Critical successes factors in setting up a successful partnered drug development project
Drug development is complex, costly, and subject to many levels of risk during the clinical phases. So, what can you do to help avoid the pitfalls of this risky business and improve your company’s chance of success?
Due to the growing complexity of molecules under development today, few will ever successfully pass through Phase III and move into successful commercial manufacturing. For this reason, many companies, particularly those with limited resources, will look to clinical outsourcing with a partner.
But what are the essential partner attributes you must look for when selecting such a partner? What are the critical successes factors in setting up a partnered drug development project successfully? And, are there methods to increase the value of your injectable drug package through CDMO cooperation?
All of these questions and more will be answered in the webinar entitled: Innovative Outsourcing Approaches: A Look Forward in the Clinical Development of Injectables on 5 December. The webinar, which begins at 16:15 GMT, will feature Dr David Brett, Product and Service Manager Vetter, and Karis Findlan, Project Manager Vetter. They will offer their insights and a case history into how a development and manufacturing partner can help create valuable long-term solutions to complex development challenges.
Webinar
Innovative Outsourcing Approaches: A Look Forward in the Clinical Development of Injectables
Thursday, 5 December 2013, 16:15 GMT
